ASO Visual Abstract: Accuracy and Survival Outcomes After National Implementation of Sentinel Lymph Node Biopsy in Early-Stage Endometrial Cancer.

S Cabrera, Gómez-Hidalgo NR, V García-Pineda, V Bebia, S Fernández-González, P Alonso, T Rodríguez-Gómez, P Fusté, M Gracia-Segovia, C Lorenzo, Enrique Chacon, Fernando Roldan Rivas, Octavio Arencibia, Maria Martí Edo, Soledad Fidalgo, Josep Sanchis, Pablo Padilla-Iserte, Manuel Pantoja-Garrido, Sergio Martínez, Ricard PeiróCecilia Escayola, M. Reyes Oliver-Pérez, Cristina Aghababyan, Carmen Tauste, Spain-GOG and the MULTISENT Study Group

Producció científica: Contribució a revistaArticleRecercaAvaluat per experts

Resum

Background: Sentinel lymph node (SLN) biopsy has recently been accepted to evaluate nodal status in endometrial cancer at early stage, which is key to tailoring adjuvant treatments. Our aim was to evaluate the national implementation of SLN biopsy in terms of accuracy to detect nodal disease in a clinical setting and oncologic outcomes according to the volume of nodal disease.

Patients and methods: A total of 29 Spanish centers participated in this retrospective, multicenter registry including patients with endometrial adenocarcinoma at preoperative early stage who had undergone SLN biopsy between 2015 and 2021. Each center collected data regarding demographic, clinical, histologic, therapeutic, and survival characteristics.

Results: A total of 892 patients were enrolled. After the surgery, 12.9% were suprastaged to FIGO 2009 stages III-IV and 108 patients (12.1%) had nodal involvement: 54.6% macrometastasis, 22.2% micrometastases, and 23.1% isolated tumor cells (ITC). Sensitivity of SLN biopsy was 93.7% and false negative rate was 6.2%. After a median follow up of 1.81 years, overall surivial and disease-free survival were significantly lower in patients who had macrometastases when compared with patients with negative nodes, micrometastases or ITC.

Conclusions: In our nationwide cohort we obtained high sensitivity of SLN biopsy to detect nodal disease. The oncologic outcomes of patients with negative nodes and low-volume disease were similar after tailoring adjuvant treatments. In total, 22% of patients with macrometastasis and 50% of patients with micrometastasis were at low risk of nodal metastasis according to their preoperative risk factors, revealing the importance of SLN biopsy in the surgical management of patients with early stage EC.
Idioma originalAnglès
Pàgines (de-a)7669-7670
Nombre de pàgines2
RevistaAnnals of Surgical Oncology
Volum30
DOIs
Estat de la publicacióPublicada - 21 d’ag. 2023

Fingerprint

Navegar pels temes de recerca de 'ASO Visual Abstract: Accuracy and Survival Outcomes After National Implementation of Sentinel Lymph Node Biopsy in Early-Stage Endometrial Cancer.'. Junts formen un fingerprint únic.

Com citar-ho